Scientists at UC San Francisco recently published the results of their Phase II Clinical Trial, which showed that an antihistamine restores nervous system function in patients with chronic multiple sclerosis (MS). In this landmark study, the antihistamine, clemastine fumarate, is the first medication that has been shown to reliably restore any brain function damaged by a neurological disease in human patients.Read More
Science Market Update
Tags: UCSF, UC San Francisco Parnassus, University of California San Francisco, sell lab products, BioResearch Product Faire, Lab Product Sales, new scince buildings, UCSF Mission Bay, laboratory equipment suppliers, SFVS, Multiple Sclerosis, clinical trials
Tags: Georgetown University, Washington DC, Northeast, Multiple Sclerosis, new science wet labs, 2012, Neuroscience, Geotwn, BioResearch Product Faire Event, Biomedical Research Funding, charitable giving
The University of Colorado's Anschutz Medical Campus has long been a leader in understanding Multiple Sclerosis (MS) with numerous clinical trials and essential basic research. Now the University plans to create the translational Research Laboratory at the Rocky Mountain MS Center, which will transform its investigation into treatment for the disease that will directly benefit patients.